Related Experiment Video
Updated: Jan 13, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
9.0K
Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical
Silas Ramos Furquim1, Maria Tereza Sampaio de Sousa Lira1, Deborah de Sá Pereira Belfort1
1Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil.
Cardiac Failure Review
|January 12, 2026
Summary
Cardiac reverse remodelling (RR) improves heart failure prognosis by restoring heart muscle structure and function. Differentiating RR from remission is key for guiding long-term patient care and treatment decisions.
Area of Science:
- Cardiology
- Heart Failure Research
Background:
- Cardiac reverse remodelling (RR) is crucial for myocardial recovery in heart failure (HF).
- Understanding RR mechanisms is vital for improving patient outcomes.
Purpose of the Study:
- To review current concepts, mechanisms, therapies, and clinical implications of cardiac reverse remodelling.
- To differentiate RR from myocardial recovery and remission in heart failure management.
Main Methods:
- Literature review of pharmacological and non-pharmacological interventions for RR.
- Analysis of clinical features, echocardiography, advanced imaging, and biomarkers for patient stratification.
- Discussion of current debates in managing HF with improved ejection fraction.
Main Results:
- Both pharmacological and non-pharmacological strategies can induce RR in select HF patients.
- Patient stratification using clinical, imaging, and biomarker data aids in predicting recovery and relapse risk.
- High recurrence rates observed upon therapy discontinuation, with partial withdrawal potentially safe in specific cases.
Conclusions:
- Cardiac reverse remodelling is a central therapeutic goal in heart failure care.
- Individualized follow-up is critical to distinguish transient improvement, remission, and true myocardial recovery for guiding long-term treatment.
Keywords:
Reverse remodellingheart failureimproved ejection fractionmyocardial recoverypharmacological therapyprognosisMore Related Videos
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
01:30Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
01:29Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
01:30Heart Failure IV: Classification and Diagnostic Evaluation
310
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
310
01:14Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
01:21Rheumatic Heart Disease III: Medical Management
277
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277